Verified Clinical Trials is all set to integrate its research participation verification tools with the clinical trial automation platform of ProofPilot in a new strategic partnership, the trial solution providers went on to announce on March 19. It is well to be noted that the terms of the deal have not been disclosed yet.
As per Chris Venezia, the CEO of ProofPilot, their objective is to give the sponsors the best chance when it comes to providing the safety as well as efficacy of their drugs by way of workflow automation. He added that with VCT, they will go ahead and streamline the sites’ ability to make sure that the right patient gets enrolled in the trials.
VCT happens to be a research subject verification service that enables the biopharma companies to keep out the duplicates or even the professional research subjects who go on to enroll across multiple trials simultaneously, a kind of issue that could very well undermine a trial’s integrity. It goes ahead and maintains global databases pertaining to clinical trial subjects that are enrolled in phases 1 through 4, such as a registry specifically pertaining to the central nervous system as well as psychiatry participants. VCT happens to be operating across 50 countries, confirms its website.
It is worth noting that new partner ProofPilot’s platform goes on to automate a broad range of tasks that happen to keep the trial protocols on track as well as consistent between sites. The company happens to offer software tool packages that, in a way, streamline workflows at the sites and also communicate with patients, like an app that sends reminders pertaining to the tasks.
